Search research articles
Contact Us
Filters
Showing results (41-50 of 225) with videos related to
Page
of 23
Sort By:
Lancet (London, England)
|
March 16, 2024
Inflammation, infection, and cardiovascular risk
Gen-Min Lin, Wei-Chun Huang, Chih-Lu Han
Circulation
|
July 15, 2015
Letter by Lin et al Regarding Article, "Prevalence and Prediction of Coronary Artery Disease in Patients With Liver Cirrhosis: A Registry-Based Matched Case-Control Study"
Gen-Min Lin, Wen-Been Wang, Chih-Lu Han
Indian Heart Journal
|
May 3, 2017
Microvascular dysfunction in silent myocardial ischemia
Chih-Lu Han, Ching-Fen Wu, Gen-Min Lin
Stroke
|
April 23, 2011
Letter by Lin et al regarding article, "Hepatitis C virus infection and increased risk of cerebrovascular disease"
Gen-Min Lin, Kai-Min Chu, Chih-Lu Han
International Journal of Cardiology
|
November 27, 2010
Pexelizumab may be hazardous to those with ST-segment elevation myocardial infarction undergoing primary percutaneous interventions without using glycoprotein IIb-IIIa inhibitors
Gen-Min Lin, Kai-Min Chu, Chih-Lu Han
The American Journal of Emergency Medicine
|
January 27, 2011
Letter for Killip classification and glucose level in patients with acute myocardial infarction
Gen-Min Lin, Yi-Hwei Li, Chih-Lu Han
Circulation
|
November 18, 2009
Letter by Kan et al regarding Article, "randomized trial of warfarin, aspirin, and clopidogrel in patients with chronic heart failure: the Warfarin and Antiplatelet Therapy in Chronic Heart failure (WATCH) trial"
Li-Ping Kan, Kai-Min Chu, Gen-Min Lin
International Journal of Cardiology
|
August 14, 2014
Elevated concentrations of high-density lipoprotein cholesterol and cardiovascular risk paradox in patients with coronary heart disease and the equivalents
Gen-Min Lin, Yi-Hwei Li, Chih-Lu Han
Circulation
|
February 24, 2010
Letter by Lin et al regarding article, "Triple versus dual antiplatelet therapy in patients with acute ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention"
Gen-Min Lin, Kai-Min Chu, Chih-Lu Han
International Journal of Cardiology
|
November 25, 2010
Reverse epidemiology reflects C-reactive protein as a bystander of atherosclerosis in established systemic inflammation models
Gen-Min Lin, Kai-Min Chu, Chih-Lu Han
Page
of 23
Search research articles
Search
Showing results (41-50 of 225) with videos related to
Sort By:
Page
of 23
Lancet (London, England)
|
March 16, 2024
Inflammation, infection, and cardiovascular risk
Gen-Min Lin, Wei-Chun Huang, Chih-Lu Han
Circulation
|
July 15, 2015
Letter by Lin et al Regarding Article, "Prevalence and Prediction of Coronary Artery Disease in Patients With Liver Cirrhosis: A Registry-Based Matched Case-Control Study"
Gen-Min Lin, Wen-Been Wang, Chih-Lu Han
Indian Heart Journal
|
May 3, 2017
Microvascular dysfunction in silent myocardial ischemia
Chih-Lu Han, Ching-Fen Wu, Gen-Min Lin
Stroke
|
April 23, 2011
Letter by Lin et al regarding article, "Hepatitis C virus infection and increased risk of cerebrovascular disease"
Gen-Min Lin, Kai-Min Chu, Chih-Lu Han
International Journal of Cardiology
|
November 27, 2010
Pexelizumab may be hazardous to those with ST-segment elevation myocardial infarction undergoing primary percutaneous interventions without using glycoprotein IIb-IIIa inhibitors
Gen-Min Lin, Kai-Min Chu, Chih-Lu Han
The American Journal of Emergency Medicine
|
January 27, 2011
Letter for Killip classification and glucose level in patients with acute myocardial infarction
Gen-Min Lin, Yi-Hwei Li, Chih-Lu Han
Circulation
|
November 18, 2009
Letter by Kan et al regarding Article, "randomized trial of warfarin, aspirin, and clopidogrel in patients with chronic heart failure: the Warfarin and Antiplatelet Therapy in Chronic Heart failure (WATCH) trial"
Li-Ping Kan, Kai-Min Chu, Gen-Min Lin
International Journal of Cardiology
|
August 14, 2014
Elevated concentrations of high-density lipoprotein cholesterol and cardiovascular risk paradox in patients with coronary heart disease and the equivalents
Gen-Min Lin, Yi-Hwei Li, Chih-Lu Han
Circulation
|
February 24, 2010
Letter by Lin et al regarding article, "Triple versus dual antiplatelet therapy in patients with acute ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention"
Gen-Min Lin, Kai-Min Chu, Chih-Lu Han
International Journal of Cardiology
|
November 25, 2010
Reverse epidemiology reflects C-reactive protein as a bystander of atherosclerosis in established systemic inflammation models
Gen-Min Lin, Kai-Min Chu, Chih-Lu Han
Page
of 23